Sass, M. R., Danielsen, A. A.
, Köhler-Forsberg, O., Storgaard, H., Knop, F. K., Nielsen, M. Ø., Sjödin, A. M.
, Mors, O., Correll, C. U., Ekstrøm, C., Vinberg, M., Nielsen, J., Vilsbøll, T. & Fink-Jensen, A. (2023).
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry).
BMJ Open,
13(1), Article e068652.
https://doi.org/10.1136/bmjopen-2022-068652
Nordentoft, I. K., Birkenkamp-Demtröder, K., Christensen, E., Deochand, S., Maloney, D., Danielle, A.
, Lindskrog, S. V., Agerbæk, M., Jensen, J. B., Oklander, B., Zviran, A.
& Dyrskjøt, L. (2022).
Abstract 540: Genome-wide circulating tumor DNA for monitoring treatment response and metastatic relapse in bladder cancer. Poster session presented at AACR ANNUAL MEETING 2022 New Orleans, New Orleans, Louisiana, United States.